Lv4
430 积分 2024-02-19 加入
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease from a Large Tertiary Center
2个月前
已完结
Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
2个月前
已完结
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
5个月前
已完结
Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review
5个月前
已完结
Epidemiology and risk factors for IBD
5个月前
已完结
皖公网安备34019202002308
